Neuralink

As of Oct 26, 2026, Neuralink's estimated valuation is $48.19B; its last round was a Series E on Jun 2, 2025, raising $486.75M at a $9.64B valuation. Pre-IPO exposure trades as perpetual futures on Gate and as tokens from PreStocks.

Neuralink

Neurotechnology

Estimated Valuation$48.19B

Valuation As OfOct 26, 2026

Latest Raise$486.75M

Latest RoundSeries E

Latest Funding Valuation$9.64B

Latest Funding DateJun 2, 2025

Loading chart...

About Neuralink

Neuralink is Elon Musk's brain-computer interface company developing implantable chips that connect the human brain to computers, aimed at helping people with paralysis and eventually enabling broader human-AI interaction.

Funding rounds

Round
Jun 2, 2025Series E$486.75M$9.64B
Aug 7, 2023Series D$323.2M$3.49B
Jul 29, 2021Series C$205M$2.15B
May 10, 2019Series B-1$156,279$575.09M
Apr 29, 2019Series B$51M-
Aug 25, 2017Series A$107M$142.67M

Perpetual markets

ExchangeTypeContract
GateCEXgate:NEURALINK_USDT$438.2$0$8,711.420%$438.2B

Token issuers

IssuerBacking
PreStocksSPV interest$410.4153$1.07M-

Frequently asked questions

What is Neuralink's estimated valuation?

As of Oct 26, 2026, Neuralink's latest tracked valuation estimate is $48.19B.

When was Neuralink's last funding round?

Neuralink's latest tracked funding round was a Series E on Jun 2, 2025, raising $486.75M at a $9.64B valuation.

Where can I get pre-IPO exposure to Neuralink?

As of Oct 27, 2026, Neuralink pre-IPO exposure trades as perpetual futures on Gate and as tokens from PreStocks.

Valuation and funding data updated Oct 27, 2026, 6:56 PM UTC.

Market data updated Oct 27, 2026, 6:56 PM UTC.